Literature DB >> 18538129

Hypoxia upregulates the histone demethylase JMJD1A via HIF-1.

Sven Wellmann1, Maxi Bettkober, Andrea Zelmer, Karl Seeger, Marion Faigle, Holger K Eltzschig, Christoph Bührer.   

Abstract

The histone demethylase Jumonji domain containing 1A (JMJD1A) demethylates H3K9 residues and thereby transactivates distinct target genes. Investigating the effect of hypoxia on JMJD1A expression, we found increased JMJD1A mRNA in different organs of rats exposed to normobaric hypoxia (8% O(2)). Compared to adult samples, JMJD1A was increased in most tissues of human fetuses in whom oxygen supply is low compared to postnatal levels. Upregulation of JMJD1A mRNA and protein in cultured human cells exposed to hypoxia or iron scavengers in vitro was abrogated when hypoxia-inducible factor-1 (HIF-1) signaling was blocked by siRNAs. A single pivotal hypoxia responsive element (HRE) in the promoter of the human JMJD1A gene was identified that mediates JMJD1A upregulation by hypoxia, iron scavengers, and HIF-1. These findings demonstrate that JMJD1A can be stimulated by hypoxia both in vitro and in vivo involving binding of HIF-1 to a specific HRE in the JMJD1A promoter.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538129     DOI: 10.1016/j.bbrc.2008.05.150

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  93 in total

Review 1.  Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia.

Authors:  Almut Grenz; Dirk Homann; Holger K Eltzschig
Journal:  Antioxid Redox Signal       Date:  2011-04-11       Impact factor: 8.401

2.  Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A.

Authors:  Imari Mimura; Masaomi Nangaku; Yasuharu Kanki; Shuichi Tsutsumi; Tsuyoshi Inoue; Takahide Kohro; Shogo Yamamoto; Takanori Fujita; Teppei Shimamura; Jun-ichi Suehiro; Akashi Taguchi; Mika Kobayashi; Kyoko Tanimura; Takeshi Inagaki; Toshiya Tanaka; Takao Hamakubo; Juro Sakai; Hiroyuki Aburatani; Tatsuhiko Kodama; Youichiro Wada
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

Review 3.  The promise and failures of epigenetic therapies for cancer treatment.

Authors:  Pasano Bojang; Kenneth S Ramos
Journal:  Cancer Treat Rev       Date:  2013-07-05       Impact factor: 12.111

Review 4.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

5.  HIF activation causes synthetic lethality between the VHL tumor suppressor and the EZH1 histone methyltransferase.

Authors:  Abhishek A Chakraborty; Eijiro Nakamura; Jun Qi; Amanda Creech; Jacob D Jaffe; Joshiawa Paulk; Jesse S Novak; Kshithija Nagulapalli; Samuel K McBrayer; Glenn S Cowley; Javier Pineda; Jiaxi Song; Yaoyu E Wang; Steven A Carr; David E Root; Sabina Signoretti; James E Bradner; William G Kaelin
Journal:  Sci Transl Med       Date:  2017-07-12       Impact factor: 17.956

6.  Control of histone H3 lysine 9 (H3K9) methylation state via cooperative two-step demethylation by Jumonji domain containing 1A (JMJD1A) homodimer.

Authors:  Satoshi Goda; Takayuki Isagawa; Yoko Chikaoka; Takeshi Kawamura; Hiroyuki Aburatani
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

7.  The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF.

Authors:  Sophie Beyer; Malene Maag Kristensen; Kim Steen Jensen; Jens Vilstrup Johansen; Peter Staller
Journal:  J Biol Chem       Date:  2008-11-04       Impact factor: 5.157

8.  An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia.

Authors:  Yair Benita; Hirotoshi Kikuchi; Andrew D Smith; Michael Q Zhang; Daniel C Chung; Ramnik J Xavier
Journal:  Nucleic Acids Res       Date:  2009-06-02       Impact factor: 16.971

9.  Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones.

Authors:  Jason E Fish; Matthew S Yan; Charles C Matouk; Rosanne St Bernard; J J David Ho; J J David Ho; Anna Gavryushova; Deepak Srivastava; Philip A Marsden
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

10.  Mechanisms of c-myc degradation by nickel compounds and hypoxia.

Authors:  Qin Li; Thomas Kluz; Hong Sun; Max Costa
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.